Sabrina Taylor, DO
Family Medicine · Sioux Falls, SDNPI 1275948986
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 35.5% of the total. Reporting peaked in 2022 at $765 and has fallen 97.5% since, to $19 in 2023. Among family medicine clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 190 payments — averaging $11.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$775
- Amgen$240
- AstraZeneca$187
- Biohaven Pharmaceutical Holding Company Ltd.$172
- GSK$106
- Astellas Pharma US Inc$74
- plus $631 from 19 others
What the payments were for
- Food & beverage$2,185100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 84 | $775 |
| Amgen | 20 | $240 |
| AstraZeneca(2 entities) | 14 | $187 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $172 |
| GSK | 8 | $106 |
| Astellas Pharma US Inc | 5 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Amarin Pharma, Inc. | 5 | $68 |
| Lilly USA, LLC | 5 | $67 |
| Pfizer | 5 | $65 |
| Novo Nordisk | 4 | $60 |
| Johnson & Johnson | 4 | $52 |
| Boehringer Ingelheim | 3 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Abbott | 2 | $29 |
| Mylan Specialty L.p. | 2 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| La Jolla Pharmaceutical Company | 1 | $19 |
| Novartis | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Inogen, Inc. | 1 | $10 |
How this compares
$2,185 in reported general payments places this provider in the 90th percentile of 408 family medicine providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $32,440 |
| OzempicSemaglutide | 13 | $12,511 |
| JardianceEmpagliflozin | 14 | $10,595 |
| XareltoRivaroxaban | 29 | $9,599 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 19 | $8,964 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,717 |
| Levothyroxine Sodium | 150 | $1,311 |
| Rosuvastatin Calcium | 91 | $1,303 |
| Gabapentin | 75 | $1,017 |
| Atorvastatin Calcium | 127 | $941 |
| Duloxetine Hcl | 26 | $889 |
| Memantine Hcl ErMemantine Hcl | 21 | $827 |
| Pantoprazole Sodium | 47 | $719 |
| Omeprazole | 81 | $683 |
| Amlodipine Besylate | 99 | $552 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $65 | $32,44033 claims |
| Novo NordiskOzempic | $60 | $12,51113 claims |
| Boehringer IngelheimJardiance | $36 | $10,59514 claims |
| Johnson & JohnsonXarelto | $52 | $9,59929 claims |
| GSKAnoro Ellipta | $106 | $8,96419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 408 family medicine providers in South Dakota.
Other family medicine in Sioux Falls
- Andrew BurchettSioux Falls$13K
- Lornell HansenSioux Falls$11K
- Jeffry MeyerSioux Falls$8K
- Scott BoyensSioux Falls$6K
- Jason WurthSioux Falls$4K
- Dustin SnellingSioux Falls$4K
- William BuchnerSioux Falls$3K
- Jennifer SchrieverSioux Falls$2K
- Nicole MourelatosSioux Falls$2K
- Joseph MowerySioux Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.